These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 10727476)

  • 1. Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies.
    Giovannoni G; O'Sullivan JD; Turner K; Manson AJ; Lees AJ
    J Neurol Neurosurg Psychiatry; 2000 Apr; 68(4):423-8. PubMed ID: 10727476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recognition of a dopamine replacement therapy dependence syndrome in Parkinson's disease: a pilot study.
    Bearn J; Evans A; Kelleher M; Turner K; Lees A
    Drug Alcohol Depend; 2004 Dec; 76(3):305-10. PubMed ID: 15561481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypomania and mania related to dopamine replacement therapy in Parkinson's disease.
    Maier F; Merkl J; Ellereit AL; Lewis CJ; Eggers C; Pedrosa DJ; Kalbe E; Kuhn J; Meyer TD; Zurowski M; Timmermann L
    Parkinsonism Relat Disord; 2014 Apr; 20(4):421-7. PubMed ID: 24467817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hedonistic homeostatic dysregulation in Parkinson's disease and excess dopamine replacement therapy.
    Grosset K; Grosset D
    Mov Disord; 2005 Sep; 20(9):1230-1. PubMed ID: 16037920
    [No Abstract]   [Full Text] [Related]  

  • 5. Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies.
    Cantello R
    J Neurol Neurosurg Psychiatry; 2000 Oct; 69(4):566-7. PubMed ID: 11183044
    [No Abstract]   [Full Text] [Related]  

  • 6. Impulse control disorders in Parkinson's disease.
    Stacy M
    F1000 Med Rep; 2009 May; 1():. PubMed ID: 20948752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compulsive use of dopamine replacement therapy in Parkinson's disease: reward systems gone awry?
    Lawrence AD; Evans AH; Lees AJ
    Lancet Neurol; 2003 Oct; 2(10):595-604. PubMed ID: 14505581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and clinical features of hedonistic homeostatic dysregulation in Parkinson's disease.
    Pezzella FR; Colosimo C; Vanacore N; Di Rezze S; Chianese M; Fabbrini G; Meco G
    Mov Disord; 2005 Jan; 20(1):77-81. PubMed ID: 15390130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic review on the applications of resting-state fMRI in Parkinson's disease: Does dopamine replacement therapy play a role?
    Tahmasian M; Bettray LM; van Eimeren T; Drzezga A; Timmermann L; Eickhoff CR; Eickhoff SB; Eggers C
    Cortex; 2015 Dec; 73():80-105. PubMed ID: 26386442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Punding in non-demented Parkinson's disease patients: Relationship with psychiatric and addiction spectrum comorbidity.
    Pettorruso M; Fasano A; De Risio L; Ricciardi L; Di Nicola M; Martinotti G; Janiri L; Bentivoglio AR
    J Neurol Sci; 2016 Mar; 362():344-7. PubMed ID: 26944176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine dysregulation syndrome in Parkinson's disease: a systematic review of published cases.
    Warren N; O'Gorman C; Lehn A; Siskind D
    J Neurol Neurosurg Psychiatry; 2017 Dec; 88(12):1060-1064. PubMed ID: 29018160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compulsive use of dopamine replacement therapy: a model for stimulant drug addiction?
    Ambermoon P; Carter A; Hall W; Dissanayaka N; O'Sullivan J
    Addiction; 2012 Feb; 107(2):241-7. PubMed ID: 21793971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of hedonistic homeostatic dysregulation.
    Kessel BL
    Age Ageing; 2006 Sep; 35(5):540-1. PubMed ID: 16799178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevalence and clinical characteristics of hypersexuality in patients with Parkinson's disease following dopaminergic therapy: A systematic literature review.
    Nakum S; Cavanna AE
    Parkinsonism Relat Disord; 2016 Apr; 25():10-6. PubMed ID: 26923525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine dysregulation syndrome in non-Parkinson's disease patients: a systematic review.
    Cartoon J; Ramalingam J
    Australas Psychiatry; 2019 Oct; 27(5):456-461. PubMed ID: 31032624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Punding in Parkinson's disease: its relation to the dopamine dysregulation syndrome.
    Evans AH; Katzenschlager R; Paviour D; O'Sullivan JD; Appel S; Lawrence AD; Lees AJ
    Mov Disord; 2004 Apr; 19(4):397-405. PubMed ID: 15077237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paradoxical effect of dopamine medication on cognition in Parkinson's disease: relationship to side of motor onset.
    Hanna-Pladdy B; Pahwa R; Lyons KE
    J Int Neuropsychol Soc; 2015 Apr; 21(4):259-70. PubMed ID: 25923830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular basis of dopamine replacement therapy and its side effects in Parkinson's disease.
    You H; Mariani LL; Mangone G; Le Febvre de Nailly D; Charbonnier-Beaupel F; Corvol JC
    Cell Tissue Res; 2018 Jul; 373(1):111-135. PubMed ID: 29516217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reward pathways in Parkinson's disease: clinical and theoretical implications.
    Torta DM; Castelli L
    Psychiatry Clin Neurosci; 2008 Apr; 62(2):203-13. PubMed ID: 18412844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of asymmetric dopamine depletion on sensitivity to rewarding and aversive stimuli in Parkinson's disease.
    Maril S; Hassin-Baer S; Cohen OS; Tomer R
    Neuropsychologia; 2013 Apr; 51(5):818-24. PubMed ID: 23422331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.